Apellis Pharmaceuticals, Inc.·4

Jul 24, 5:01 PM ET

Machiels Alec 4

4 · Apellis Pharmaceuticals, Inc. · Filed Jul 24, 2023

Insider Transaction Report

Form 4
Period: 2023-07-21
Transactions
  • Exercise/Conversion

    Common Stock

    2023-07-21$2.67/sh+49,779$132,910367,420 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-07-2149,7795,000 total
    Exercise: $2.67Exp: 2023-12-04Common Stock (49,779 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    11,950
  • Common Stock

    (indirect: By LLC)
    250,000
  • Common Stock

    (indirect: By Trust)
    150,000
Footnotes (4)
  • [F1]The shares are held by Bauhaus 1 LLC, which LLC is held by The Irrevocable Agreement of Trust of Alec Machiels (the "Trust"). The reporting person is the managing member of Bauhaus 1 LLC and the trustee of the Trust.
  • [F2]Owned by spouse.
  • [F3]On September 7, 2021, the reporting person's spouse transferred 150,000 shares of Apellis Pharmaceuticals, Inc. common stock to her trust, of which the reporting person is the trustee.
  • [F4]This option was granted on December 5, 2013 and fully vested.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT